2010 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. All rights reserved.
P/N:BROCHURES-450305-201004
Mindray is listed on the NYSE under the ticker “MR”
Mindray Building, Keji 12th Road South, High-tech Industrial Park, Nanshan, Shenzhen 518057, P.R. ChinaTel: +86 755 26582888 Fax: +86 755 26582680Website: www.mindray.com
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
MISSION
VISIONWe will make better healthcare solutions
more accessible to humanity.
Improve healthcare by optimizing
and sharing medical technologies with the world.
1
3
5
7
9
15
17
19
21
CONTENTS
Profile
Global Expansion
Customer Focus
R&D
Products
Manufacturing & Quality
Our Services
Corporate Citizenship
Milestones
Shenzhen is a beautiful coastal city in South China, and is one
of the “31 Places to Go in 2010” listed by The New York Times.
Shenzhen borders Hong Kong and covers an area of 1,953 km²
(754 sq. miles) with over ten million (2008 est.) inhabitants.
After becoming the first special Chinese economic zone in
1980, i t grew into a prosperous metropolis with an
astounding annual growth rate of 15% , boasting the highest
GDP per capita in mainland China. This young and vibrant city
is impressive not only in terms of growth, but also in the
strength of its industries like hi-tech, finance, foreign trade,
exports and shipping.
The hi-tech industr y contributes nearly one third to
Shenzhen's GDP, firmly making the city the “Silicon Valley” of
China. Innovation is the industry’s growth engine, and the
greatest innovations happening in China can be found in
Shenzhen's Hi-Tech Park where Mindray is headquartered.
Mindray , High-Tech Industrial Park, Shenzhen, ChinaHeadquarters
Profile
Who We Are
On September 26, 2006 Mindray was successfully listed on the
New York Stock Exchange(NYSE), the largest exchange in the
world by dollar volume. The NYSE listing not only recognizes
our efforts and excellence in improving corporate operations
and providing quality products for the past 15 years, but also
g i v e s M i n d r a y a g l o b a l p r e s e n c e a l o n g w i t h n e w
opportunities and challenges. The listing was part of a long-
term plan to implement the best practices in all aspects of our
business including R&D, manufacturing, quality control, sales,
distribution, finance and corporate governance.
In accordance with international laws, standards and
practices, we are becoming a formidable global competitor
and we’re proud to say that customer confidence is at an all
time high. Our Initial Public Offering and changes in
management clearly shows that Mindray is serious about
every step we take to realizing our vision.
Sustainable growth has always been a major focus for the
company, and the foundation we have laid over the
1 2
past several years has proven valuable for continued and
sustainable growth: R&D and new product launches have
been accelerated. The domestic market lead has been
sustained and further expanded and overseas expansion has
been steadily growing. Behind this consistent and substantial
growth is our focus on Mindray’s core mission : to produce the
finest medical devices at affordable prices, and make them
available to the greatest number of people in China and
worldwide.
Mindray was founded in 1991 with the goal of delivering
high-quality, competitively priced medical devices to make
healthcare more accessible and affordable around the world.
In 2006, Mindray listed on the New York Stock Exchange and is
now a leading developer, manufacturer and marketer of
medical devices worldwide.
The company has three well-established business segments:
Patient Monitoring and Life Support Products, In-Vitro
Diagnostic Products and Medical Imaging Systems. Health
care facilities equipped with Mindray's products can be found
in over 190 countries and regions. A sound distribution and
service network has been formed with 29 branch offices
throughout China, and overseas subsidiaries in Brazil,
Ca n a d a , Fra n ce, I n d i a , I n d o n e s i a , I t a l y, M e x i co, t h e
Netherlands, Russia, Turkey, the UK and the USA. Additionally,
t h e a c q u i s i t i o n o f D a t a s c o p e Co r p o r a t i o n ' s p a t i e n t
monitoring business has added significant direct sales and
service capabilities on the ground in the U.S. and Western
Europe.
Mindray has a global R&D network with research centers in
Shenzhen, Bei j ing, Nanj ing, Seatt le, New Jersey and
Stockholm. Over 1,400 engineers are employed in the network
and approximately 10% of total revenue has been consistently
invested into R&D each year. An average of eight new products
have annually been introduced to the market over the past
seven years.
A Public Listed Company
3 4
Subsidiary company established
To be established
R&D Center
London
Amsterdam
Frankfurt
Paris
Moscow
Istanbul29 Branch Offices
Milan
Mumbai
Toronto
Mexico City
Seattle
New Jersey
Sao Paulo
HQ in Shenzhen
Jakarta
Stockholm
Beijing
Nanjing
Santa Fe de Bogota
New DelhiCairo
Madrid
R&D Center Mahwah, NJ, USA,
Global Expansion
Global Strategy Broadens Our VisionIn 1992, we expanded the playing field by launching the first
Pulse Oximeter in the Chinese patient monitoring market.
Then we developed two other product lines that were firsts in
the domestic market: In-Vitro Diagnostic Products and
Medical I maging Systems. I n 2000, we entered the
international market and found that high functionality, top
quality and superior cost efficiency had proven to be as
popular in the global markets as they were at home. Exposure
to the international marketplace has broadened our vision,
spurred innovation and inspired management. Our dream to
become a world-class developer, manufacturer and marketer
of medical devices is now much closer and within our grasp.
Market Leader in China
Mindray is the market leader in China and our products have
been used in over 40,000 medical facilities, including
renowned hospitals like Peking Union Medical College
Hospital and Fudan University Zhongshan Hospital.
According to a Frost &Sullivan report, in 2007 Mindray
attained a leading market share in China in terms of number
of units sold and total revenues for patient monitoring
devices. In addition to patient monitoring devices, Mindray
also holds a leading position in China for sales in diagnostic
laboratory instruments and grey scale ultrasound imaging
systems sales.
Mindray has an extensive sales and distribution network
across thirty major cities to guarantee rapid fulfillment and
maximum customer satisfaction. Along with effective
customer-oriented R&D and a steady launch of new products,
Mindray’s reliable service is key to helping the company
sustain growth and expand its market leading position.
Rapid International Presence
At the outset in 2000, Mindray focused on growth in the
European and North American markets, and has since
successfully penetrated over 190 countries and regions.
Worldwide recognition of the quality and cost-effectiveness
of Mindray’s products has driven healthy sales growth across
three major product lines. In 2009 international sales
contributed 53.9% of the total revenue.
Mindray's overseas operations have been designed to
facilitate client interaction with our localized team of
specialists. This has created a strong bond and forstered
client loyalty. Additionally, Mindray has gained greater
insight into different cultures, which has increased the
company ’s abi l i t y to cater to specia l requirements.
Localization and frequent exposure in industry media and
participation in exhibitions such as MEDICA, AACC, ECR and
RSNA, have also enhanced brand awareness in the local
markets.
Reliable quality and competitive pricing have helped
Mindray to win open bids for public health projects
worldwide such as those sponsored by The World Bank and
UNFPA.
Accelerated Expansion of International Sales Channel
In May 2008, a little over a year after the IPO, Mindray took
another giant step in global expansion by acquiring the
patient monitoring business of the U.S.-headquartered
Datascope Corporation, becoming the third-largest player in
the global patient monitoring device industry.
Mindray’s integration with Datascope has been seamless and
we remain on track with our expected synergies. We have and
will continue to leverage Datascope's well-established sales
and service channels in the United States and Western Europe
to enhance the distribution of Mindray's existing product
lines. Mindray also expects to further benefit from the
synergies created by combining our strong China-based
engineering and production platforms with Datascope's
established brands, long-standing reputation for high-quality
products and service, and both companies' leading R&D
capabilities.
Customer Demand Motivates Innovation
5 6
Medical Park Bahchelevler Hospital, Turkey
Customer Focus
Customer demand is the source of our innovation, and
fulfilling customers' needs is at the heart of Mindray's
corporate values. Our philosophy to create satisfied customers
is reflected throughout all of our operations including R&D,
manufacturing, sales and services.
Healthcare scenarios are becoming increasingly complicated,
and every situation poses different challenges to care delivery
organizations and clinicians. In order to have in-depth
knowledge of the problems, processes and requirements of
our customers and help them cope with ever-changing
environments, we work closely with them and provide tailored
solutions.
Overseas subsidiaries contribute greatly to strengthening
customer relationships and addressing concerns. Reference
hospitals in different countries also enable us to collect more
specific concerns and valuable feedback from end users.
Internally, a unique feedback loop records, sorts and analyzes
customer feedback on real-life medically diverse product
experiences. Our R&D engineers incorporate pertinent
feedback into product design and upgrades, offering product
solutions for specific needs. This continuous running loop
supports and sustains the scalable potential for our products
and provides our customers with valuable products.
Medical professionals employ Mindray products in medical clinics around the world.
Mindray employees receive and analyze feedback based on real-life product experiences from diverse medical environments.
Sales and service representatives demonstrate the advantages of Mindray products specifically designed to meet the needs of medical professionals.
Global R&D teams incorporate feedback and offer product solutions to address the specific needs of end users.
Enhanced product designs come to life in state-of-the-art
manufacturing facilities.
Institut Hospitalier Jacques Cartier, Paris
Shenzhen R&D Center, China
R & D
Mindray's R&D network realizes the synergies that exist
between its world-class research talents and infrastructure.
Committed Investment
We invest approximately 10% of our net revenues back into
R&D each year. Mindray has three overseas R&D centers in
Seattle, Mahwah and Stockholm to focus on more advanced
medical device technologies and to form a global research
network in tandem with the three R&D centers in China.
As of December 2009, there are more than 1,400 engineers in
the network. We have established a full range of professional
labs like EMC, and Respiratory Gases and Reagents, which
contribute greatly to the company's intellectual property
position.
Constant Innovation
Consistent innovation gives rise to products with superior
functionality and a higher performance-to-price ratio.
Sufficient pre-research is done for every new product and
there have been key technological breakthroughs. As of
December 2009, we have obtained 960 technology patents
or patent applications.
Quality Orientation
Every single research project, large or small, is subjected to
strict worldwide quality criteria from the very beginning,
such as ISO9001/13485 and CMDC. Design, testing and
engineering processes are established to comply with FDA
regulations and CE standards to maintain top notch safety
and reliability for products used by customers all over the
world.
Diversified Product Portfolio
With a large and efficient R&D platform, we have been able to
launch 7-9 new products across the three major segments
each year since 2002 while continuously providing technical
solutions to drive down costs. We have already built a product
portfolio of more than 70 products.Beijing R&D Center, China
Nanjing R&D Center, China
7 8
Seattle R&D Center, WA, USA
Mahwah R&D Center, NJ, USA
R&D Ensures Sustainable Growth
Stockholm R&D Center, Sweden
Patient Monitor
Patient Monitoring and Life Support Products
2006 Global Market Penetration Leadership Award
2007 Patient Monitoring Global Excellence Award
Products
Since the launch of the first Pulse Oximeter in 1992, Mindray
has revolutionized patient monitors through its in-depth
knowledge of international medical quality standards. As our
technologies improve, our monitoring systems continue to
provide value for hospitals, offering ease of use, unique
compact designs, and access to leading technology.
BeneView, our high-end patient monitor series first launched
in 2006, offers a thorough modular design that is highly
flexible and can be adjusted to work with ICG, RM, BIS and
other high-end parameters, enabling clinicians to adjust
medical care methodologies in a timely and effective manner.
Our WATO anesthesia machine, also first launched in 2006, has
been widely acclaimed for its advanced ventilation modes and
its use on patients in all age groups. WATO's sophisticated
monitoring technologies allow this system to be integrated
with Mindray's patient monitors and other medical devices,
further improving safety and patient care quality.
Answering the clinical demand for integrated solutions, we
have recently launched a total solution for the OR and ICU. The
solution includes new products like ceiling supply units,
medical beam systems and surgical lights and tables,
alongside existing high-end monitors and anesthesia
machines.
9 10
BeneView T6/T8Patient Monitor
VS-800 Vital Signs Monitor
WATO EX-65Anesthesia Machine
Anesthesia Machine
Central Station
Vital Signs
Multi-Parameter
Defibrillator/Monitor
Hypervisor VICentral Monitoring System
iPM-9800Patient Monitor
Operating Table & Surgical Lights
BeneHeart D6Defibrillator/Monitor
PM-7000Patient Monitor
HyLite 6 SeriesSurgical Lights
HyBase 6100Operating Table
OR Solution
OR Solution
2010 European Patient Monitoring Excellence in Globalisation Award
In-Vitro Diagnostic Products Cytometr y, which is used to achieve precise 5-par t
differentiation of leucocytes.
Our chemistry analyzer product line offers state-of-the-art
sample loading, optical, incubation and washing systems with
user-friendly software to ensure accuracy and precision of
laboratory tests with the capability to process 100 to 400 tests
per hour.
Over 55,000 of Mindray’s hematology products have been
installed in 150 countries. The company’s In-Vitro Diagnostic
segment aims to offer quality products at a competitive price
to its customers around the world. Mindray is well positioned
to introduce additional innovative products and solutions for
clinical laboratories in the near future.
Products
In 1998, we launched the first semi-automatic 3-part
differential hematology analyzer in China. In 2003, we
marketed the first automatic chemistry analyzer with full
intel lec tual proper ty r ights in China. Af ter years of
development, this division offers products that meet the
requirements of hematology, chemistr y, immunology,
reagent and related quality assurance systems.
The hematology analyzer product line is comprised of 3-part
and 5-par t di f ferential analyzer systems. Our 3-par t
hematology analyzer models are available in semi-automatic
or automatic forms, and can process 30 to 60 tests per hour.
Our 5-par t hematology analyzer is a lso avai lable in
semiautomatic or automatic forms, and applies laser scatter
technology combined with a chemical dye method and flow
11 12
BC-5800Auto Hematology Analyzer
BS-380Auto Chemistry Analyzer
Hematology Reagents
Chemistry Reagents
5-part Diff Hematology Analyzers
Chemistry Analyzers
Elisa System
Reagents
3-part Diff Hematology Analyzers
BS-120Auto Chemistry Analyzer
BC-3000PlusAuto Hematology Analyzer
MR-12A Microplate Washer
BS-800MChemistry Analysis System
M i n d r a y h a s s p e c i a l i z e d i n t h e d e v e l o p m e n t a n d
manufacturing of high quality ultrasound systems for over 13
years and the company was the first to launch a high-end
digital B&W ultrasound device in China in 2001. Subsequently,
a series of outstanding ultrasound products have been
developed, providing versatile diagnostic solutions for
different application fields.
Our broad range of ultrasound products include: cart-based
and hand–carried Color Doppler systems, and cart-based and
portable B&W systems. As an innovator in ultrasound imaging
systems, Mindray delivers imaging technologies that bring a
new level of image quality and functionality to ensure
diagnostic confidence.
Our ultrasound systems serve a wide range of applications,
like abdominal, gynecology, obstetrics, cardiology, small
parts, urology, orthopedics, vascular and more. The variety of
measurement and calculation software packages enable
clinicians to obtain more useful diagnostic information and
Medical Imaging Systemsthe systems are designed with excellent ergonomics and
intuitive workflow, making our devices user-friendly.
Mindray has gained popularity in the diagnostic ultrasound
market with its expertise in revolutionary new imaging
technologies, extraordinary ergonomic design and strict
quality control. Since 2008 we have introduced digital
radiography systems: the DigiEye 560 with U-arm assembly
and the DigiEye 760 with Ceil ing Suspension, which
established a new area for Mindray's medical imaging system.
The compact solution to DR technology from Mindray fits
every clinical space and helps increase the intelligent
operation.
Products
13 14
DC-6 ExpertDiagnostic Ultrasound System
DP-6900Digital Ultrasonic Diagnostic
Imaging System
Hand-carried Color Doppler System
Cart-based Color Doppler System
Cart-based Black & White System
Portable Black & White System
DC-7Diagnostic Ultrasound System
DP-9900Digital Ultrasonic Diagnostic
Imaging System
M5 Hand-carried Diagnostic Ultrasound System
2010 Reddot Design Award
DigiEye 560Digital Radiography System
Digital Radiography System
M7 Hand-carried Diagnostic Ultrasound System
DC-3Diagnostic Ultrasound System
2 75,000m Manufacture Center
Manufacturing & Quality Scalable Manufacturing Assures Cost-efficiency
Patient Monitor Product Line
Chemistry Analyzer Product Line Ultrasound Product Line
Hematology Analyzer Product LineAnesthesia Machine Product Line
Digital Control Machine Tools Workshop
At Mindray, R&D, manufacturing, marketing and customer
ser vice are considered to be equally impor tant. Our
leadership position in the marketplace does not come from
an intense focus on a single division, but from the synergistic
excellence of all.
We improve cost-eff iciency through several methods
including increasing the percentage of components on a
cost-basis and manufactured in-house, standardizing
components across product lines to gain economies of scale
and through active management of our supply chain
relationships.
In order to meet rising customer demand, a new 75,000
square meter manufacturing center for patient monitors,
hematology analyzers, medical consumables and key
accessories has been added to the 21,000 square meter
manufacturing facility for hematology, chemistry reagent and
radioactive immures.
15 16
We have adopted a flexible manufacturing system (FMS)
which fully reflects the uniqueness of the medical device
industry. This flexibility allows Mindray to react accordingly in
response to unique customer demands from different regions
while securing production capacity. The highly scalable
system embodies obvious technical and cost advantages
when a new product enters the production phase.
Company-wide quality awareness contributes greatly to our
corporate personality. We are committed to quality in all
aspects of our business and believe that TUV ISO 9001 is a
prime example of that dedication.
At Mindray, every detail matters. From development to
packaging, every single detail is recorded and standardized
for the sake of high efficiency and uncompromising quality.
Quality consistency and manufacturing efficiency are secured
by systems and methodologies like ERP, TQM and 5S. Stringent
quality control provides the flexibility needed to meet
customized orders in a precise and timely manner.
1995 TUV Ps ISO 9001, the first one in China's medical device industry
2000 Quality system certification of CMDC
2000 CE Mark for patient monitoring products
2003 CE Mark for ultrasound imaging systems
2003 CE Mark for clinical laboratory instruments
2004 FDA 510(k) clearance for patient monitoring products
2005 FDA 510(k) clearance for ultrasound imaging system
2006 Certified by UL for the Safety Test Lab, the first one in China's medical device industry
2007 FDA 510(k) clearance for hematology analyzer
2007 Reliability Test Lab certified by CNAS, the first one in China's medical device industry
2008 FDA 510(k) clearance for chemistry analyzer
2009 Certified by ETL for the Safety Test Lab
2009 Standardization Lab certified by CNAS, the first one in China’s medical device industry
Achievements of Quality Pursuit
Flexible on-site training
Our Services
Service Increases Product Value
17 18
Our motto is to “be speedy, professional and efficient” and is
best embodied in our after-sales service to our customers
worldwide. At Mindray, we keep in mind that customers
demand more than just quality products. Customers need a
reliable partner with enough resources to offer differentiated,
high-valued services.
With 29 branch offices in China and over ten overseas
subsidiaries, Mindray's global service network is growing
rapidly and maintains smooth communication between
clients and our engineers. Facing a wide range of different
needs, our customer service department has developed
various training programs for distributors and hospitals to
improve flexibility and adaptability.
Our quick response impresses customers and our engineers
are highly knowledgeable and guarantee a quick response.
Our customers know that there is a sufficient spare parts
inventory, efficient response personnel and advanced CRM
systems working together to keep every case on track.
As a major component of customer care, our engineers pay
regular visits to customers, get comments on products and
show them our latest developments. We analyze and develop
proven equipment solutions to achieve greater efficiency in
daily hospital operations. By identifying potential areas for
improvement through effective customer feedback and
customized operational solutions we can truly give our
customers the service they deserve, no matter where they are
or where they go in the future.
Listen to the end user
town hospitals in Jilin, a province of Northeastern China. In
May 2009, Mindray donated medical devices to twenty-six
town hospitals in Anhui province.
The four donations were
worth a total of 22,590,000 CNY (3,307,000 USD).
Suppor t for Disaster Relief Effor ts The devastating
earthquake that shook Sichuan in Southwestern China on May
12, 2008 left thousands dead and more injured.
Upon hearing of the tragedy, the management team at
Mindray quickly offered assistance for the relief effort. Mr. Xu
Hang and Mr. Li Xiting, co-chief executives, led companywide
donations with 3,200,000 CNY (468,904 USD) worth of high-
q u a l i t y, p o r t a b l e m u l t i - p a ra m e te r p at i e nt m o n i to r s .
Employees raised a cash donation of over 1,000,000 CNY
(146,535 USD). Mindray’s humanitarian support ranges from
the turmoil of the SARS outbreak in 2003 to the tsunami
that struck the Indian Ocean in 2004. Mindray is firmly
committed to helping people in stricken communities.
Supporting Education in Underdeveloped Regions The
goal of the non-governmental Hope Project is to finance the
education of students from poor families. I t includes
p r o g r a m s t o e s t a b l i s h H o p e p r i m a r y s c h o o l s i n
underdeveloped rural areas, establish Hope scholarships in
high schools and universities, implement distance education
and train teachers for rural schools. Mindray has been part of
the national effort for years and a number of schools have
been built with company donations.
As an integral part of the community, Mindray has always
insisted on giving back. Our passion is to make the world a
better place, not only with humanitarian efforts, but also by
using our expertise to improve the health and well-being of
people everywhere in the world.
In December 2009, Mindray
donated medical devices worth 1000,000 CNY to the Family-
planning Agency in Haojiang District of Shantou, supporting
women’ s health in the rural area.
Mindray also
supports the medical establishments outside of China, in
October 2009, Mindray donated medical devices to Ethiopia.
More smiles from rural dwellers
More help to disaster relief
Corporate Citizenship
Social ResponsibilityMindray integrates prosperity, sustainability and alignment
with the environmental and social standards of the
international community. Social consciousness is a large part
of our corporate culture.
Support for Medical Establishment Medical facilities in
rural underdeveloped areas of China have lagged behind the
rapid modernization brought on by the economic boom. In
response, the central government is giving top priority to
improving the quality of care in these areas.
As a leading medical device company in China, Mindray
actively supports the nationwide effort to improve rural
healthcare condit ions by designing customized and
affordable equipment.
In July 2007, Mindray donated medical equipment to Gansu
province, in the far flung reaches of Northwestern China and
in August, Mindray donated medical devices to twenty-eight
19 20
Milestones
21
New headquarter building to be completed in 2010
1991 Founded in Shenzhen, China
1993 Developed China's first multi-parameter patient monitor
1995 ISO 9001 certified by TUV
1998 Developed China's first 3-part differential hematology analyzer
2000 Received first CE Mark clearance, began exporting products overseas
2001 Developed China's first digital diagnostic ultrasound imaging system
2003 Developed China's first automatic chemistry analyzer
2004 Received first FDA 510(k) clearance; first product exported to US Market
2006 Developed China's first 5-part differential hematology analyzer
2006 Developed China's first digital color Doppler ultrasound imaging system
2006 Listed on New York Stock Exchange under the ticker symbol “MR”
2007 Received the 2006 Global Market Penetration Leadership and the 2007 Patient Monitoring Global
Excellence Awards from the global growth consulting company Frost & Sullivan
2008 Acquired Datascope's patient monitoring business, becoming the third-largest player
in the global patient monitoring device industry
2010 Received the 2010 European Patient Monitoring Excellence in Globalization Award from Frost & Sullivan
